BlackRock Institutional Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$48.1M Buy
442,854
+5,517
+1% +$599K 0.01% 1375
2016
Q3
$72M Buy
437,337
+21,523
+5% +$3.54M 0.01% 1070
2016
Q2
$59.3M Buy
415,814
+3,813
+0.9% +$544K 0.01% 1134
2016
Q1
$52.9M Sell
412,001
-3,375
-0.8% -$434K 0.01% 1185
2015
Q4
$62M Buy
415,376
+8,379
+2% +$1.25M 0.01% 1121
2015
Q3
$67.5M Buy
406,997
+60,949
+18% +$10.1M 0.01% 1056
2015
Q2
$83.5M Buy
346,048
+17,192
+5% +$4.15M 0.01% 1001
2015
Q1
$92.7M Buy
328,856
+9,915
+3% +$2.8M 0.01% 972
2014
Q4
$49.8M Buy
318,941
+11,047
+4% +$1.72M 0.01% 1300
2014
Q3
$72.9M Buy
307,894
+8,530
+3% +$2.02M 0.01% 1027
2014
Q2
$70.8M Buy
299,364
+64,633
+28% +$15.3M 0.01% 1093
2014
Q1
$77.4M Buy
234,731
+153,164
+188% +$50.5M 0.01% 1024
2013
Q4
$5.57M Sell
81,567
-2,161
-3% -$148K ﹤0.01% 2725
2013
Q3
$5.78M Buy
83,728
+13,349
+19% +$922K ﹤0.01% 2656
2013
Q2
$3.16M Buy
+70,379
New +$3.16M ﹤0.01% 2890